Chloroquine phosphate 是一种广泛用于疟疾和类风湿性关节炎的抗疟疾和抗炎剂。Chloroquine phosphate 是 autophagy 和 toll-like receptors (TLRs) 的抑制剂。Chloroquine phosphate 有效抑制 SARS-CoV-2 (COVID-19) 感染 (EC50=1.13 μM)。
| CAS No. | 50-63-5 |
| 生物活性 | Chloroquine phosphate is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. Chloroquine phosphate is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine phosphate is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC50=1.13 μM). |
| 分子式 | C18H32ClN3O8P2 |
| 分子量 | 515.86 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存条件 | 4°C, protect from light |
| 溶解性数据 | H2O : ≥ 33 mg/mL (63.97 mM) DMSO : < 1 mg/mL (ultrasonic) (insoluble or slightly soluble) |
| 体内研究 | Chloroquine (80 mg/kg, i.p.) does not prevent the growth of the triple-negative MDA-MB-231 cells with high or low TLR9 expression levels in the orthotopic mouse model. TLR7 and TLR9 inhibition using IRS-954 or chloroquine significantly inhibits tumour growth in the mouse xenograft model. HCC development in the DEN/NMOR rat model is also significantly inhibited by chloroquine. |
| 体外研究 | Chloroquine (CHQ, 20 μM) inhibits IL-12p70 release and reduces Th1-priming capacity of activated human monocyte-derived Langerhans-like cells (MoLC). Chloroquine (CHQ, 20 μM) enhances IL-1–induced IL-23 secretion in MoLC and subsequently increases IL-17A release by primed CD4 T cells. Chloroquine (25 μM) suppresses MMP-9 mRNA expression in normoxia and hypoxia in parental MDA-MB-231 cells. Chloroquine has cell-, dose- and hypoxia-dependent effects on MMP-2, MMP-9 and MMP-13 mRNA expression. TLR7 and TLR9 inhibition using IRS-954 or chloroquine significantly reduces HuH7 cell proliferation in vitro. Chloroquine (0.01-100 μM; 48 hours) potently blocks virus infection (vero E6 cells infected with SARS-CoV-2) at low-micromolar concentration (EC50= 1.13 μM). Chloroquine blocks virus infection by increasing endosomal pH required for virus/cell fusion, as well as interfering with the glycosylation of cellular receptors of SARS-CoV. |
| 文献 | •Adv Funct Mater. 2020, 2004940. •Circ Res. 2018 May 25;122(11):1532-1544. •Nucleic Acids Res. 2021 Jan 8;49(D1):D1113-D1121. •Nucleic Acids Res. 2018 Apr 20;46(7):3284-3297. •Adv Sci (Weinh). 2019 Mar 25;6(10):1801862. •Autophagy. 2021 Dec 29;1-13. •Autophagy. 2021 Dec 8;1-23. •Autophagy. 2021 Nov 25;1-21. •Autophagy. 2021 Nov 5;1-17. •Autophagy. 2021 Mar 22;1-17. •Autophagy. 2021 Jul;17(7):1592-1613. •Autophagy. 2020 Jan;16(1):106-122. •Mol Cancer. 2019 Apr 10;18(1):85. •J Clin Invest. 2020 Jun 1;130(6):3253-3269. •Bioact Mater. 19 November 2021. •Small. 2021 Aug;17(32):e2101368. •J Pineal Res. 2021 Dec;71(4):e12774. •Redox Biol. 2021 Jan;38:101828. •Theranostics. 2021 Mar 4;11(10):4637-4654. •Theranostics. 2021 Jan 1;11(2):841-860. •Theranostics. 2020 Jul 1;10(18):8051-8060. •Clin Transl Med. 2020 Oct;10(6):e208. •Acta Pharm Sin B. 17 September 2021. •Acta Pharm Sin B. 21 July 2021. •Acta Pharm Sin B. 2020 Dec 15. •Proc Natl Acad Sci U S A. 2019 Nov 12;116(46):23332-23338. •J Exp Clin Cancer Res. 2019 Aug 14;38(1):354. •J Hazard Mater. 2022, 126770. •Oncogene. 2018 May;37(22):2936-2952. •Diabetes. 2021 Oct 21;db210240. •Cell Rep. 2021, 108959. •Aging Cell. 2020 Jul;19(7):e13171. •Br J Pharmacol. 2020 Aug;177(15):3473-3488. •Cancer Lett. 2021 Oct 28;519:2-19. •Cancer Lett. 2021 Feb 1;498:54-69. •Cancer Lett. 2020 Jul 1;481:15-23. •Cell Death Dis. 2021 Apr 20;12(5):413. •Cell Death Dis. 2020 Nov 11;11(11):969. •Cell Death Dis. 2020 Jul 30;11(7):607. •Cell Death Dis. 2020 Mar 13;11(3):183. •Cell Death Dis. 2019 Jul 22;10(8):565. •Cell Death Dis. 2019 Jun 11;10(6):456. •Cell Death Dis. 2019 Feb 11;10(2):118. •J Neuroinflammation. 2021 Jan 5;18(1):5. •EBioMedicine. 2017 May;19:49-59. •Elife. 2021 Jul 13;10:e69047. •Environ Pollut. 2020, 116413. •Sci Total Environ. 2022 Jan 2;814:152759. •Sci Total Environ. 2021, 146523. •Neurotherapeutics. 2020 Oct;17(4):1796-1812. •Front Immunol. 2021 Jul. •Front Immunol. 2021 May 18;12:662989. •Part Fibre Toxicol. 2020 Sep 18;17(1):46. •Free Radic Biol Med. 2021 Apr 22;S0891-5849(21)00265-3. •Genes Dis. 2020 Nov 21;8(6):867-881. •Genes Dis. 2021 Mar 1. •Gene Dis. 2019 May 25;7(3):401-407. •Chemosphere. 2021, 130034. •Int J Biol Macromol. 2020 Dec 1;164:2761-2768. •Cell Prolif. 2021 Oct 20;e13136. •Cell Prolif. 2019 May;52(3):e12609. •Cell Prolif. 2019 May;52(3):e12606. •PLoS Pathog. 2021 Jun 2;17(6):e1009645. •Front Cell Dev Biol. 2021 Oct 22;9:756743. •Front Cell Dev Biol. 2021 Oct 6;9:734818. •Front Cell Dev Biol. 30 March 2021. •Front Cell Dev Biol. 2021 Jan 14. •Cancers (Basel). 2021 Jul 11;13(14):3467. •Mol Oncol. 2020 Nov 23;15(2):725-738. •Int J Biol Sci. 2019 May 12;15(6):1310-1324. •Int J Biol Sci. 2019 Mar 10;15(5):942-952 •Int J Biol Sci. 2019 Jan 29;15(4):788-799. •Oxid Med Cell Longev. 2020 Oct 23;2020:2048210. •Oxid Med Cell Longev. 2020 Aug 20;2020:4964202. •Biomed Pharmacother. 2020 Jun;126:110080. •Biomed Pharmacother. 2021 Jan;133:111023. •Biomed Pharmacother. 2020 Dec 31;135:111034. •Biomed Pharmacother. 2020 Dec;132:110898. •Biomed Pharmacother. 2020 Mar;123:109811. •Biomed Pharmacother. 2019 Oct;118:109144. •Biomed Pharmacother. 2018 Dec;109:1617-1627. •Breast Cancer Res. 2021 Dec 18;23(1):116. •J Cell Physiol. 2021 May;236(5):3641-3659. •Acta Physiol (Oxf). 2019 Aug;226(4):e13272. •Ecotoxicol Environ Saf. 25 December 2021, 113028. •Front Oncol. 2021 Jun 18;11:656608. •Am J Cancer Res. 2019 Jun 1;9(6):1266-1281. •Acta Pharmacol Sin. 2021 Nov 9. •Acta Pharmacol Sin. 2021 Feb 19. •Acta Pharmacol Sin. 2020 Aug 11. •J Nutr Biochem. 2020 Jun;80:108380. •Int J Mol Sci. 2019 Feb 28;20(5):1057. •Int J Mol Sci. 2017 May 19;18(5). pii: E1063. •Biochem Pharmacol. 2021 May 3;114588. •Front Pharmacol. 19 July 2021. •Front Pharmacol. 16 July 2021. •Front Pharmacol. 2021 Jul 9;12:684915. •Neoplasia. 2021 Nov 8;23(12):1227-1239. •Aging (Albany NY). 2019 Nov 15; 11(21): 9794–9810. •Aging. 2021 Mar 10;13(7):9542-9565. •Front Microbiol. 2020 Jan 8;10:3040. •Respir Res. 2018 Dec 5;19(1):243. •Chin Med. 2021 Nov 24;16(1):123. •Food Funct. 2021 Mar 31. •Food Funct. 2019 Oct 16;10(10):6915-6926. •J Cell Mol Med. 2021 Oct;25(19):9214-9227. •J Cell Mol Med. 2021 Jul 18. •J Cell Mol Med. 2020;00:1-15. •J Cell Mol Med. 2020 Oct;24(19):11558-11572. •J Cell Mol Med. 2018 Nov;22(11):5311-5321. •Front Cell Infect Microbiol. 2020 Apr 15;10:155. •J Agric Food Chem. 2020 Nov 11;68(45):12617-12630. •Gene Ther. 2021 Aug 20. •Cell Death Discov. 2021 Dec 14;7(1):389. •Cell Death Discov. 2021 Dec 14;7(1):392. •Cell Death Discov. 2021 Sep 20;7(1):254. •Chem Biol Interact. 2018 Mar 1;283:59-74. •FASEB J. 2020 Aug;34(8):10966-10983. •Biochim Biophys Acta Mol Basis Dis. 2019 Jun 26;1865(10):2618-2632. •Atherosclerosis. 2019 Feb 22;284:1-10. •J Biol Chem. 2021, 100616. •Neural Regen Res. 2021 Apr;16(4):765-771. •J Virol. 2021 Dec 1;JVI0110321. •J Virol. 2021 Sep 29;JVI0134521. •Viruses. 2020 Jun 10;12(6):628. •Int Immunopharmacol. 2022 Jan 10;104:108443. •Int Immunopharmacol. 2020 Nov;88:106859. •J Infection. 2020 Jun;80(6):e19-e26. •Biochim Biophys Acta Mol Cell Res. 2021 Jun 1;119074. •Am J Chin Med. 2019;47(6):1405-1418. •Bioresources and Bioprocessing. 8, 4 (2021). •Cell Cycle. 2020 Sep;19(17):2216-2225. •J Funct Foods. November 2021, 104686. •Eur J Pharmacol. 2020 Nov 5;886:173526. •J Cell Biochem. 2020 Jun;121(5-6):3333-3344. •Vaccines. 2020 Jan 13;8(1):22. •Molecules. 2019 Mar 20;24(6):1091. •Mol Immunol. 2021 Dec 21;141:318-327. •Bone. 2021 Nov 20;116262. •Sci Rep. 2020 May 7;10(1):7714. •Sci Rep. 2020 Mar 5;10(1):4126. •Sci Rep. 2018 Mar 7;8(1):4108. •Sci Rep. 2017 Jun 7;7(1):2929. •Toxicol Lett. 2020 Mar 15;321:32-43. •Toxicol Appl Pharmacol. 31 December 2021, 115857. •Toxicol Appl Pharmacol. 2020 Dec 15;409:115271. •Toxicol Appl Pharmacol. 2020 Nov 15;407:115241. •Nutr Metab. 2021 Sep 9;18(1):83. •Nutr Metab. 2021 Feb 18;18(1):20. •Drug Des Dev Ther. 2021 Aug 21;15:3643-3659. •Drug Des Devel Ther. 2020 May 18;14:1897-1908. •J Physiol Biochem. 2021 Apr 22;1-11. •Oncotargets Ther. 2021 Jan 8;13:13437-13450. •Environ Toxicol. 2021 Nov 29. •Prostate. 2019 Jan;79(1):44-53. •Int J Mol Med. 2021 Jul;48(1):124. •Int J Mol Med. 2020 Jan;45(1):245-254. •Int J Mol Med. 2018 May;41(5):2535-2544. •Virol J. 2019 Jul 18;16(1):90. •Inflammation. 2020 Aug;43(4):1510-1523. •J Pharmacol Exp Ther. 2018 Oct;367(1):20-27. •Neurochem Res. 2021 Oct 27;1-12. •Neurotox Res. 2020 Dec;38(4):859-870. •Oncol Rep. 2021 Feb 3. •Exp Cell Res. 2018 Dec 15;373(1-2):211-220. •Exp Cell Res. 2018 Feb 15;363(2):160-170. •PLoS Negl Trop Dis. 2019 Aug 20;13(8):e0007681. •Invest New Drugs. 2021 Jan 2. •Acta Biochim Biophys Sin (Shanghai). 2018 Feb 1;50(2):144-155. •Acta Biochim Biophys Sin (Shanghai). 2016 Dec;48(12):1075-1084. •Chem Res Toxicol. 2019 Dec 16;32(12):2509-2516. •Biomed J. 2020 Aug;43(4):368-374. •Endocrine. 2020 Dec;70(3):526-537. •Neuroscience. 2021 Feb 15;S0306-4522(21)00080-4. •Biochem Biophys Res Commun. 27 July 2021. •Biochem Biophys Res Commun. 2021 Mar 4;550:15-21. •Biochem Biophys Res Commun. 2020 Dec 10;533(3):474-480. •Biochem Biophys Res Commun. 2020 Jul 12;528(1):105-111. •Biochem Biophys Res Commun. 2020 Feb 19;522(4):862-868. •Biochem Biophys Res Commun. 2018 Sep 5;503(2):501-507. •Mol Cell Biochem. 2020 Sep;472(1-2):219-230. •Drug Chem Toxicol. 2021 Sep 22;1-12. •DNA Cell Biol. 2020 Mar;39(3):368-378. •Vet Microbiol. 2021, 109177. •Vet Microbiol. 2021, 109103. •J Diabetes. 2019 Oct;11(10):826-836. •J Zhejiang Univ Sci B. 2020 Jul;21(7):560-570. •Neurosci Lett. 2019 Nov 1;712:134485. •Neurosci Lett. 2018 Aug 24;682:112-117. •Oncol Lett. 2021 Mar 29. •Hum Exp Toxicol. 2021 Jul 5;9603271211030554. •J Microbiol. 2020 Apr;58(4):320-329. •Theriogenology. 1 January 2022, Pages 1-10. •Theriogenology. 2019 Dec;140:44-51. •Evid Based Complement Alternat Med. 2021 Sep 16;2021:8548380. •Exp Ther Med. September 16, 2021. •Exp Ther Med. July 5, 2021. •Biol Open. 2020 Nov 12;9(11):bio053298. •In Vitro Cell Dev Biol Anim. 2019 Oct;55(9):703-712. •Can J Physiol Pharmacol. 2020 Jul;98(7):449-458. •Cancer Invest. 2019;37(6):242-252. •Anticancer Agents Med Chem. 2017;17(8):1093-1101. •J Med Virol. 2021 Jun 1. •J Med Entomol. 2021 May 15;58(3):1202-1209. •Research Square Preprint. 2021 Oct. •Research Square Preprint. 2021 Aug. •Research Square Preprint. 2021 May. •Research Square Preprint. 2021 Mar. •Research Square Preprint. 2021 Feb. •Research Square Preprint. 2020 Oct. •Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Transmissores de Hematozoários. 2020 Sep. •bioRxiv. 2020 Jun. •Cell Physiol Biochem. 2018;48(6):2318-2336. •Oncotarget. 2017 Nov 22;8(65):109135-109150. •Tumour Biol. 2016 Jul;37(7):8811-24. |
| 纯度及产品资料 | 98% |
邮箱：info@TianyaBio.com
电话：020-3107 8154
地址：广州市番禺区兴业大道东路1078号2-50
微信公众号
微信客服
